arBtrage CAPITALIZING MARKETS checking… Sign in

Catalyst Pharmaceuticals, Inc.

CPRX Health Care Biotechnology: Pharmaceutical Preparations
$31.27
▼ -0.1% Today
as of Jun 7, 07:12 ET
Last 30 days +6.22% Apr 28 → Jun 05
$27.87 $28.80 $29.73 $30.66 $31.59 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$31.29
High
$31.30
Low
$31.27
Volume
$1M
Avg Vol
$2M
Mkt Cap
$3.8B
P/E (TTM)
23.51
Beta
52w High
$32.56
52w Low
$19.05
Div Yield
Shares Out
$122M

Overview

52-week range
$19
$33
90% of range
Avg surprise (last 2)
+25.6%
Avg reaction (last 2)
+0.9%
50% positive
Latest IV / EM
57%
EM ±7.8% · $30 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.29$-0.03$0.23$0.48$0.74 Actual $0.33Actual $-0.29Actual $0.19Actual $0.33Actual $0.35Actual $0.63Est $0.51Actual $0.41Actual $0.42Actual $0.74Est $0.58 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$0$17M$33M$50M$67M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 11, 2026Mar/2026 $0.74 $0.58 +27.6% +17.5% 0.0% earnings
Tue Sep 30, 2025Sep 2025 $0.42 financials
Mon Jun 30, 2025Jun 2025 $0.41 financials
Wed May 7, 2025Mar/2025 $0.63 $0.51 +23.5% +1.7% earnings
Mon Sep 30, 2024Sep 2024 $0.35 financials
Sun Jun 30, 2024Jun 2024 $0.33 financials
Sun Mar 31, 2024Mar 2024 $0.19 financials
Sat Sep 30, 2023Sep 2023 $-0.29 financials
Fri Jun 30, 2023Jun 2023 $0.33 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$73M$66M$66M$63M$51M$54M
Net income$64M$53M$52M$57M$44M$41M
EPS (diluted)$0.50$0.42$0.41$0.45$0.35$0.33

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$756M$709M$690M$653M$581M$518M$442M$376M
Inventory$35M$37M$28M$19M$20M$20M$20M$18M
Total current assets$940M$894M$852M$759M$686M$624M$539M$474M
Total assets$1.15B$1.10B$1.05B$972M$909M$851M$772M$706M
Long-term debt
Total liabilities$135M$150M$131M$116M$115M$124M$111M$98M
Total equity$1.01B$954M$920M$856M$794M$728M$661M$609M

Implied volatility — last 90 days

51%54%56%59%61% Jun 07 — IV 57% · EM ±7.8%

Sector peers